117 related articles for article (PubMed ID: 34596257)
1. Surveillance genome sequencing reveals multiple SARS-CoV-2 variants circulating in central Texas, USA, with a predominance of delta variant and review of vaccine breakthrough cases.
Mutnal MB; Johnson S; Mohamed N; Abddelgader R; Morales L; Volz M; Walker K; Arroliga AC; Rao A
J Med Virol; 2022 Mar; 94(3):937-944. PubMed ID: 34596257
[TBL] [Abstract][Full Text] [Related]
2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
3. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas.
Christensen PA; Olsen RJ; Long SW; Snehal R; Davis JJ; Ojeda Saavedra M; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Mangham R; Pena S; Trinh T; Kinskey JC; Williams G; Olson R; Gollihar J; Musser JM
Am J Pathol; 2022 Apr; 192(4):642-652. PubMed ID: 35123975
[TBL] [Abstract][Full Text] [Related]
4. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.
Farinholt T; Doddapaneni H; Qin X; Menon V; Meng Q; Metcalf G; Chao H; Gingras MC; Avadhanula V; Farinholt P; Agrawal C; Muzny DM; Piedra PA; Gibbs RA; Petrosino J
BMC Med; 2021 Oct; 19(1):255. PubMed ID: 34593004
[TBL] [Abstract][Full Text] [Related]
5. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
[TBL] [Abstract][Full Text] [Related]
6. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
[TBL] [Abstract][Full Text] [Related]
8. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
McKeigue PM; McAllister DA; Hutchinson SJ; Robertson C; Stockton D; Colhoun HM
Lancet Respir Med; 2022 Jun; 10(6):566-572. PubMed ID: 35227416
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
10. Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences.
Olsen RJ; Christensen PA; Long SW; Subedi S; Hodjat P; Olson R; Nguyen M; Davis JJ; Yerramilli P; Saavedra MO; Pruitt L; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Finkelstein IJ; Gollihar J; Musser JM
Am J Pathol; 2021 Oct; 191(10):1754-1773. PubMed ID: 34303698
[TBL] [Abstract][Full Text] [Related]
11. Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas.
Christensen PA; Olsen RJ; Long SW; Subedi S; Davis JJ; Hodjat P; Walley DR; Kinskey JC; Ojeda Saavedra M; Pruitt L; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Mangham R; Pena S; Trinh T; Yerramilli P; Nguyen M; Olson R; Snehal R; Gollihar J; Musser JM
Am J Pathol; 2022 Feb; 192(2):320-331. PubMed ID: 34774517
[TBL] [Abstract][Full Text] [Related]
12. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Variants of Concern.
Choi JY; Smith DM
Yonsei Med J; 2021 Nov; 62(11):961-968. PubMed ID: 34672129
[TBL] [Abstract][Full Text] [Related]
14. Genetics, structure, transmission, epidemiology, immune response, and vaccine efficacies of the SARS-CoV-2 Delta variant: A comprehensive review.
Li H; Arcalas CJ; Song J; Rahmati M; Park S; Koyanagi A; Lee SW; Yon DK; Shin JI; Smith L
Rev Med Virol; 2023 May; 33(3):e2408. PubMed ID: 36420676
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Detection and COVID-19 Diagnosis: A Bird's Eye View.
Alzahrani AR; Jabeen Q; Shahid I; Al-Ghamdi SS; Shahzad N; Rehman S; Algarni AS; Bamagous GA; AlanazI IMM; Ibrahim IAA
Rev Recent Clin Trials; 2023; 18(3):181-205. PubMed ID: 37069722
[TBL] [Abstract][Full Text] [Related]
16. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
Paul P; France AM; Aoki Y; Batra D; Biggerstaff M; Dugan V; Galloway S; Hall AJ; Johansson MA; Kondor RJ; Halpin AL; Lee B; Lee JS; Limbago B; MacNeil A; MacCannell D; Paden CR; Queen K; Reese HE; Retchless AC; Slayton RB; Steele M; Tong S; Walters MS; Wentworth DE; Silk BJ
MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):846-850. PubMed ID: 34111060
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
18. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
[TBL] [Abstract][Full Text] [Related]
19. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.
Harris JR; Owusu D; O'Laughlin K; Cohen AL; Ben Hamida A; Patel JC; Freeman MM; Nsibambi T; Nieves R; Marston BJ; Wasike S; Galbraith JS; Boore AL; Nelson LJ; Guagliardo SAJ; Klena JD; Patel K; Ma M
Emerg Infect Dis; 2022 Jun; 28(6):1279-1280. PubMed ID: 35470796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
